Recently, researchers have developed various biomaterials and therapeutic agents to reduce tumor hypoxia, including hemoglobin, catalase (CAT), manganese dioxide NPs, oxygen shuttle nanoperfluorinated compounds (nanoPFCs), hyaluronidase (HAase), and metformin (Met). This evidence concerns the gene CAT and neoplasm.